Harvest Fund Management Co., LTD Horizon Therapeutics Public LTD CO Transaction History

Harvest Fund Management Co., LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$62.39 - $113.8 $43,298 - $78,977	694 New	694 $79,000
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $23,950 - $29,138	243 Added 18.44%	1,561 $168,000
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $3,216 - $3,862	-35 Reduced 2.59%	1,318 $144,000
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $97,185 - $129,184	1,353 New	1,353 $124,000
Q4 2020 Feb 10, 2021	SELL	$67.0 - $84.39 $268,268 - $337,897	-4,004 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$55.23 - $79.93 $60,145 - $87,043	1,089 Added 37.36%	4,004 $326,000
Q2 2020 Aug 12, 2020	SELL	$30.2 - $56.98 $19,992 - $37,720	-662 Reduced 18.51%	2,915 $160,000
Q1 2020 May 08, 2020	BUY	$24.87 - $38.56 $88,959 - $137,929	3,577 New	3,577 $105,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

Stay updated on Harvest Fund Management Co., LTD with notifications on news.